Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use in medicaments
    2.
    发明授权
    Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use in medicaments 有权
    取代的3-苯基-5-烷氧基-1,3,4-恶二唑-2-酮,它们的制备及其在药物中的用途

    公开(公告)号:US06596742B1

    公开(公告)日:2003-07-22

    申请号:US09655373

    申请日:2000-09-05

    IPC分类号: A61K314245

    CPC分类号: C07D271/113

    摘要: Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones of the formula 1 in any optically isomeric form, and their physiologically acceptable salts, where R1 is C1-C6-alkyl, C3-C9-cycloalkyl, both of which may be unsubstituted or substituted, and R2 and R3 independently of one another are hydrogen, C6-C10-aryl, C3-C8-cycloalkyl, C6-C10-aryloxymethyl, O-benzyl, O—C6-C10-aryl, O—C3-C8-cycloalkyl, O—C1-C6-alkyl, SO2—NH—C1-C6-alkyl, SO2—NH-(2,2,6,6-tetramethylpiperidin-4-yl), SO2—NH—C3-C8-cycloalkyl, SO2—N(C1-C6-alkyl)2 or COX, where X is O—C1-C6-alkyl, NH—C1-C6-alkyl, NH—C3-C8-cycloalkyl or N(C1-C6-alkyl)2, with the proviso that the substitutents R2 and R3 may in some instances be unsubstituted or substituted and are not both simultaneously hydrogen. A process for their preparation, and their inhibitory effect on the hormone-sensitive lipase, HSL.

    摘要翻译: 以任何光学异构体形式的取代的3-苯基-5-烷氧基-1,3,4-恶二唑-2-酮及其生理上可接受的盐,其中R 1是C 1 -C 6 - 烷基,C 3 -C 9 - 环烷基, 两者可以是未取代的或取代的,R 2和R 3彼此独立地是氢,C 6 -C 10 - 芳基,C 3 -C 8 - 环烷基,C 6 -C 10 - 芳氧基甲基,O-苄基,O-C 6 -C 10 - 芳基, O-C 3 -C 8 - 环烷基,O-C 1 -C 6烷基,SO 2 -NH-C 1 -C 6烷基,SO 2 -NH-(2,2,6,6-四甲基哌啶-4-基),SO 2 -NH- C 3 -C 8 - 环烷基,SO 2 -N(C 1 -C 6 - 烷基)2或COX,其中X是O-C 1 -C 6烷基,NH-C 1 -C 6烷基,NH-C 3 -C 8环烷基或N -C 1-6 - 烷基)2,条件是取代基R2和R3在一些情况下可以是未取代的或取代的,并且不同时是氢。 其制备方法及其对激素敏感性脂肪酶HSL的抑制作用。

    Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals
    3.
    发明授权
    Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals 有权
    取代的3-苯基-5-烷氧基-1,3,4-恶二唑-2-酮,它们的制备及其作为药物的用途

    公开(公告)号:US06369088B2

    公开(公告)日:2002-04-09

    申请号:US09799082

    申请日:2001-03-06

    IPC分类号: C07D271113

    摘要: Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones of the formula 1 are described, in which R1 is substituted C1-C6-alkyl and C3-C9-cycloalkyl, R2, R3, R4 and R5 are hydrogen, halogen, nitro, C1-C4-alkyl, C1-C9-alkyloxy, substituted C6-C10-aryl-C1-C4-alkyloxy, C6-C10-aryloxy, C6-C10-aryl, C3-C8-cycloalkyl or O—C3—C8-cycloalkyl, or 2-oxopyrrolidin-1-yl, 2,5-dimethylpyrrol-1-yl or NR6-A-R7, with the proviso that R2, R3, R4 and R5 are not simultaneously hydrogen, and at least one of the radicals R2, R3, R4 or R5 is the radical 2-oxopyrrolidin-1-yl, 2,5-dimethylpyrrol-1-yl or NR6-A-R7, wherein R6=hydrogen, C1-C4-alkyl or substituted C6-C10-aryl-C1-C4-alkyl, A=a single bond, COn, SOn or CONH, n=1 or 2, R7=hydrogen, substituted C1-C18-alkyl, C2-C18-alkenyl, C6-C10-aryl-C1-C4-alkyl, C5-C8-cycloalkyl-C1-C4-alkyl, C5-C8-cycloalkyl, C6-C10-aryl-C2-C6-alkenyl, C6-C10-aryl, biphenylyl, biphenylyl-C1-C4-alkyl, indanyl, or the group Het-(CH2)r—, wherein r=0, 1, 2 or 3 and Het=a saturated or unsaturated 5-7-membered heterocycle, which may be optionally benzo-fused and optionally substituted, and proceses for their preparation. The compounds of formula 1 show an inhibitory effect on hormone-sensitive lipase, HSL.

    摘要翻译: 描述了式1的取代的3-苯基-5-烷氧基-1,3,4-恶二唑-2-酮,其中R 1是取代的C 1 -C 6 - 烷基和C 3 -C 9 - 环烷基,R 2,R 3,R 4和 R 5是氢,卤素,硝基,C 1 -C 4 - 烷基,C 1 -C 9 - 烷氧基,取代的C 6 -C 10 - 芳基-C 1 -C 4 - 烷氧基,C 6 -C 10 - 芳氧基,C 6 -C 10 - 芳基,C 3 -C 8 - 或O-C 3 -C 8 - 环烷基或2-氧代吡咯烷-1-基,2,5-二甲基吡咯-1-基或NR6-A-R7,条件是R2,R3,R4和R5不同时为氢, 并且基团R 2,R 3,R 4或R 5中的至少一个是基团2-氧代吡咯烷-1-基,2,5-二甲基吡咯-1-基或NR6-A-R7,其中R6 =氢,C1-C4- 烷基或取代的C 6 -C 10 - 芳基-C 1 -C 4烷基,A =单键,COn,SO n或CONH,n = 1或2,R 7 =氢,取代的C 1 -C 18烷基,C 2 -C 18 - 烯基, C 6 -C 10 - 芳基-C 1 -C 4烷基,C 5 -C 8 - 环烷基-C 1 -C 4烷基,C 5 -C 8 - 环烷基,C 6 -C 10 - 芳基-C 2 -C 6 - 烯基,C 6 -C 10 - 芳基,联苯基, 联苯基-C 1 -C 4烷基,二氢化茚基或Het-(CH 3)